Christoph Brackmann

All filings by Christoph Brackmann on record concern Novocure Ltd. We count 7 filings; the first trade dates from 4 March 2025 and the latest from 4 March 2026.

The open-market side counts 3 purchases for €201k alongside 1 sale for €73k. On balance, insiders were net buyers of €127k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants. In 2026 alone, the filings show no purchases and 1 sale.

Half of the purchases are above €50k and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The record was last updated on 5 March 2026 with an open-market sale (€73k) in Novocure Ltd. The latest purchase dates back some time: it was published 450 days ago, on 30 July 2025. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.